The documentary special "Living Proof," produced by Sheryl Lee Ralph, will premiere on Hulu on Dec. 1 in honor of World AIDS ...
The U.S. just shipped two million doses of lenacapavir, a groundbreaking twice-a-year HIV-prevention injectable medication, ...
Gilead Sciences, Inc. is rated a Buy with robust profitability, solid dividend, prudent M&A and 15-20% upside potential. Read ...
Merck said on Wednesday its experimental oral HIV medicine was found to be non-inferior to Gilead Sciences' top-selling drug ...
The Bay Area Reporter reports that Delta Air Lines isn’t covering long-acting injectable PrEP, or the oral PrEP drug Descovy, ...
Medicaid provides health coverage for disabled and low-income populations, and the ACA expansion gives states the option to extend coverage to adults with up to 138% of the federal poverty line.
About 1,000 doses of Gilead Sciences Inc's drug lenacapavir were delivered to Zambia and Eswatini last Thursday, U.S. and ...
The United States, whose deep cuts to foreign aid this year under President Trump have severely impacted Africa’s health ...
Medicaid expansion under the Affordable Care Act (ACA) significantly increased the number of people at risk of HIV diagnosis ...